These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15208047)

  • 1. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera.
    Jain J; Dutton C; Nicosia A; Wajszczuk C; Bode FR; Mishell DR
    Contraception; 2004 Jul; 70(1):11-8. PubMed ID: 15208047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing tips for Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):4. PubMed ID: 12343462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera.
    Halpern V; Brache V; Taylor D; Lendvay A; Cochón L; Jensen JT; Dorflinger LJ
    Fertil Steril; 2021 Apr; 115(4):1035-1043. PubMed ID: 33485608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously.
    Segall-Gutierrez P; Taylor D; Liu X; Stanzcyk F; Azen S; Mishell DR
    Contraception; 2010 Jun; 81(6):487-95. PubMed ID: 20472115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraceptive efficacy and safety of DMPA-SC.
    Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
    Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of different doses of Depo Provera.
    Fotherby K; Koetsawang S; Mathrubutham M
    Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate.
    Taylor DJ; Halpern V; Brache V; Bahamondes L; Jensen JT; Dorflinger LJ
    Contracept X; 2022; 4():100073. PubMed ID: 35281554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depo-Provera: an injectable contraceptive.
    Wigington S
    Nurs Times; 1981 Oct 14-20; 77(42):1794-8. PubMed ID: 6458020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trial.
    Halpern V; Fuchs R; Brache V; Bahamondes L; Miranda MJ; Lendvay A; Cochón L; Taylor D; Dorflinger LJ
    Contracept X; 2021; 3():100070. PubMed ID: 34746745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depo-provera: contraceptive risk?
    Rosenfield A
    Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teens and Depo-Provera: a good match?
    Contracept Technol Update; 1995 Jul; 16(7):86-8. PubMed ID: 12346507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term contraceptive effect of injectable progestogens: inhibition and reestabilishment of fertility.
    Zañartu J
    Int J Fertil; 1968; 13(4):415-26. PubMed ID: 4178183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA advisory panel recommends approval for Depo-Provera.
    Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable contraceptives: how safe are they?
    Initiatives Popul; 1979; 5(4):2-10. PubMed ID: 12338524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 mL) contraceptive formulation in Asian women.
    Toh YC; Jain J; Rahnny MH; Bode FR; Ross D
    Clin Ther; 2004 Nov; 26(11):1845-54. PubMed ID: 15639696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm.
    Halpern V; Combes SL; Dorflinger LJ; Weiner DH; Archer DF
    Contraception; 2014 Jan; 89(1):31-5. PubMed ID: 23993431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depo-Provera: an injectable contraceptive.
    Earl DT; David DJ
    Am Fam Physician; 1994 Mar; 49(4):891-4, 897-8. PubMed ID: 8116522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our experiences with the use of contraceptive preparation Depo-Provera].
    Bruchác D; Sklovský A
    Cesk Gynekol; 1972 Sep; 37(7):516-7. PubMed ID: 4562178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.